Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

Ovarian

The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant Ovarian Cancer.
Ovarian
III
Crispens, Marta
NCT03398655
VICCGYN18180

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: